Prevalence of Lymphoma in IBD
The recruitment status of this study is unknown because the information has not been verified recently.
Verified December 2007 by Indiana University.
Recruitment status was Active, not recruiting
Recruitment status was Active, not recruiting
Sponsor:
Indiana University
Information provided by:
Indiana University
ClinicalTrials.gov Identifier:
NCT00577538
First received: December 19, 2007
Last updated: NA
Last verified: December 2007
History: No changes posted
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Patients with inflammatory bowel disease (IBD) may be at increased risk of lymphoma. The majority of lymphomas in patients with IBD occur in areas of active inflammation. The relationship between IBD and lymphoproliferative disease is however unclear, since both chronic inflammation as well as medications used to treat IBD (especially immunosuppressives - Azathioprine or 6-MP - and anti-TNF alpha agents) have been associated with increased risk of lymphoma. We plan to study the association between IBD and lymphoma in a large, mixed, community based and referral population from the IBD database at Indiana University.
| Condition |
|---|
|
Lymphoma Inflammatory Bowel Disease |
| Study Type: | Observational |
| Study Design: | Observational Model: Case Control Time Perspective: Retrospective |
| Official Title: | Prevalence and Risk Factor for Lymphoproliferative Disease in Patients With Inflammatory Bowel Disease |
Resource links provided by NLM:
Further study details as provided by Indiana University:
| Estimated Enrollment: | 6 |
| Study Start Date: | April 2006 |
| Estimated Study Completion Date: | December 2007 |
| Groups/Cohorts |
|---|
| 1 |
| 2 |
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Probability Sample |
Study Population
Patients diagnosed with both Inflammatory bowel disease and lymphoma over the last 30 years.
Criteria
Inclusion Criteria:
- Inflammatory Bowel disease
- Lymphoma
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00577538
Locations
| United States, Indiana | |
| Indiana University Medical Center | |
| Indianapolis, Indiana, United States, 46202 | |
Sponsors and Collaborators
Indiana University
Investigators
| Principal Investigator: | Michael V. Chiorean, M.D. | Indiana University |
More Information
No publications provided
| Responsible Party: | Michael Chiorean M.D., Indiana University |
| ClinicalTrials.gov Identifier: | NCT00577538 History of Changes |
| Other Study ID Numbers: | 060358, IRB# 0603-58 |
| Study First Received: | December 19, 2007 |
| Last Updated: | December 19, 2007 |
| Health Authority: | United States: Institutional Review Board |
Additional relevant MeSH terms:
|
Inflammatory Bowel Diseases Intestinal Diseases Lymphoma Lymphoproliferative Disorders Gastroenteritis Gastrointestinal Diseases |
Digestive System Diseases Neoplasms by Histologic Type Neoplasms Lymphatic Diseases Immunoproliferative Disorders Immune System Diseases |
ClinicalTrials.gov processed this record on May 16, 2013